Ensysce Biosciences Inc (NASDAQ: ENSC) Increases 17.86% Over A Month, But Analysts Still See Upside Potential

Ensysce Biosciences Inc (NASDAQ:ENSC) currently has a daily average trading volume of 1.72M but it saw 3389445 shares traded in last market. With a market cap of 5.48M USD, the company’s current market price of $2.31 came rising about 11.59 while comparing to the previous closing price of $2.07. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.67 and as low as $1.62.

Taking a look at 20-day trading activity of Ensysce Biosciences Inc (ENSC) gives us an average price of $2.47, while its current price level is -84.25% below from 52-week high level whereas it is 42.59% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.96 while that of 200 days or SMA-200 reads an average of $5.61. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.62% during that period while stretching the period over a month that increases to 14.03%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 44.99 which implies that the stock is in neutral territory.

Over the week, ENSC’s stock price is moving 12.68% up while it is 17.86% when we observe its performance for the past one month. Year-to-date it is -71.62% down and over the past year, the stock is showing a downside performance of -70.61%.

The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -1.61 while estimate for next year EPS is -4.72.

Currently, Ensysce Biosciences Inc’s total number of outstanding shares is 2.37M with 0.63% of that held by the insiders while 10.11% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -223.55% and return on equity (ROE) at -200.53%. Stock’s beta reads 1.00. Stock has a price to book (P/B) ratio of 1.25 while price to sale or P/S ratio amounts to 0.88. Its return on asset (ROA) is -140.74% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.